PPARG and colitis: Recentstudies have revealed 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis to besignificantly reduced after the administration of both PPARγ and RXR agonists, and this beneficial effect is reflected by thereduction in the NF-κB DNA binding activity in the colon [68].